Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 85 to 96 of 98 entries
Sorted by: Best Match Show Resources per page
Single-source precursors for alloyed gold-silver nanocrystals - a molecular metallurgy approach.

Inorganic chemistry

Zopes D, Hegemann C, Schläfer J, Tyrra W, Mathur S.
PMID: 25856772
Inorg Chem. 2015 Apr 20;54(8):3781-7. doi: 10.1021/ic502924s. Epub 2015 Apr 09.

Multiple silver(I)-aurates(I) have been prepared by salt metathesis reactions that act as efficient single-source precursors to colloidal gold silver alloys with the highest possible atom economy in the chemical synthesis of nanostructures. The CF3 group present on the Au...

Cite
Zopes D, Hegemann C, Schläfer J, et al. Single-source precursors for alloyed gold-silver nanocrystals - a molecular metallurgy approach. Inorg Chem. 2015;54(8):3781-7doi: 10.1021/ic502924s.
Zopes, D., Hegemann, C., Schläfer, J., Tyrra, W., & Mathur, S. (2015). Single-source precursors for alloyed gold-silver nanocrystals - a molecular metallurgy approach. Inorganic chemistry, 54(8), 3781-7. https://doi.org/10.1021/ic502924s
Zopes, David, et al. "Single-source precursors for alloyed gold-silver nanocrystals - a molecular metallurgy approach." Inorganic chemistry vol. 54,8 (2015): 3781-7. doi: https://doi.org/10.1021/ic502924s
Zopes D, Hegemann C, Schläfer J, Tyrra W, Mathur S. Single-source precursors for alloyed gold-silver nanocrystals - a molecular metallurgy approach. Inorg Chem. 2015 Apr 20;54(8):3781-7. doi: 10.1021/ic502924s. Epub 2015 Apr 09. PMID: 25856772.
Copy Download .nbib Format: NLM
Ink-jetable patterning of metal-catalysts for regioselective growth of nanowires.

Nanoscale

Zopes D, von Hagen R, Müller R, Fiz R, Mathur S.
PMID: 20683541
Nanoscale. 2010 Oct;2(10):2091-5. doi: 10.1039/c0nr00131g. Epub 2010 Aug 04.

Nanosized (20-30 nm) colloidal gold, silver and their alloys were obtained by reductive transformation of corresponding metal salts. Dispersions of metal nanoparticles (σ < 4%) in aqueous solutions were obtained by appropriate surface functionalization which led to inorganic inks...

Cite
Zopes D, von Hagen R, Müller R, et al. Ink-jetable patterning of metal-catalysts for regioselective growth of nanowires. Nanoscale. 2010;2(10):2091-5doi: 10.1039/c0nr00131g.
Zopes, D., von Hagen, R., Müller, R., Fiz, R., & Mathur, S. (2010). Ink-jetable patterning of metal-catalysts for regioselective growth of nanowires. Nanoscale, 2(10), 2091-5. https://doi.org/10.1039/c0nr00131g
Zopes, David, et al. "Ink-jetable patterning of metal-catalysts for regioselective growth of nanowires." Nanoscale vol. 2,10 (2010): 2091-5. doi: https://doi.org/10.1039/c0nr00131g
Zopes D, von Hagen R, Müller R, Fiz R, Mathur S. Ink-jetable patterning of metal-catalysts for regioselective growth of nanowires. Nanoscale. 2010 Oct;2(10):2091-5. doi: 10.1039/c0nr00131g. Epub 2010 Aug 04. PMID: 20683541.
Copy Download .nbib Format: NLM
Kinetic Properties of Phosphoenolpyruvate Carboxylase in Peperomia camptotricha.

Plant physiology

Sipes DL, Ting IP.
PMID: 16667110
Plant Physiol. 1989 Nov;91(3):1050-5. doi: 10.1104/pp.91.3.1050.

Kinetic characteristics of phosphoenolpyruvate carboxylase (PEPC) from the epiphytic C(3) or C(4): CAM intermediate plant, Peperomia camptotricha, were investigated. Few day versus night differences in V(max),K(m(PEP))), or malate inhibition were observed, even in extracts from water-stressed plants which characteristically...

Cite
Sipes DL, Ting IP. Kinetic Properties of Phosphoenolpyruvate Carboxylase in Peperomia camptotricha. Plant Physiol. 1989;91(3):1050-5doi: 10.1104/pp.91.3.1050.
Sipes, D. L., & Ting, I. P. (1989). Kinetic Properties of Phosphoenolpyruvate Carboxylase in Peperomia camptotricha. Plant physiology, 91(3), 1050-5. https://doi.org/10.1104/pp.91.3.1050
Sipes, D L, and Ting, I P. "Kinetic Properties of Phosphoenolpyruvate Carboxylase in Peperomia camptotricha." Plant physiology vol. 91,3 (1989): 1050-5. doi: https://doi.org/10.1104/pp.91.3.1050
Sipes DL, Ting IP. Kinetic Properties of Phosphoenolpyruvate Carboxylase in Peperomia camptotricha. Plant Physiol. 1989 Nov;91(3):1050-5. doi: 10.1104/pp.91.3.1050. PMID: 16667110; PMCID: PMC1062117.
Copy Download .nbib Format: NLM
MATLAB®-based fitting method to evaluate survival fractions after multimodal treatment.

Clinical and translational radiation oncology

Marzec J, Marzec L, Martus P, Zips D, Müller AC.
PMID: 29928704
Clin Transl Radiat Oncol. 2018 Mar 29;10:36-41. doi: 10.1016/j.ctro.2018.03.003. eCollection 2018 Mar.

To easily analyse and visualize cell kill dynamics measured by survival fraction after single or combined treatments a MATLAB®-based application was developed. A statistical analysis with different options of visualisation of single and combined treatment effects can be performed...

Cite
Marzec J, Marzec L, Martus P, et al. MATLAB®-based fitting method to evaluate survival fractions after multimodal treatment. Clin Transl Radiat Oncol. 2018;10:36-41doi: 10.1016/j.ctro.2018.03.003.
Marzec, J., Marzec, L., Martus, P., Zips, D., & Müller, A. C. (2018). MATLAB®-based fitting method to evaluate survival fractions after multimodal treatment. Clinical and translational radiation oncology, 1036-41. https://doi.org/10.1016/j.ctro.2018.03.003
Marzec, Jolanta, et al. "MATLAB®-based fitting method to evaluate survival fractions after multimodal treatment." Clinical and translational radiation oncology vol. 10 (2018): 36-41. doi: https://doi.org/10.1016/j.ctro.2018.03.003
Marzec J, Marzec L, Martus P, Zips D, Müller AC. MATLAB®-based fitting method to evaluate survival fractions after multimodal treatment. Clin Transl Radiat Oncol. 2018 Mar 29;10:36-41. doi: 10.1016/j.ctro.2018.03.003. eCollection 2018 Mar. PMID: 29928704; PMCID: PMC6008626.
Copy Download .nbib Format: NLM
Organ Preservation in Rectal Cancer: The Patients' Perspective.

Frontiers in oncology

Gani C, Gani N, Zschaeck S, Eberle F, Schaeffeler N, Hehr T, Berger B, Fischer SG, Claßen J, Zipfel S, Rödel C, Teufel M, Zips D.
PMID: 31134146
Front Oncol. 2019 May 10;9:318. doi: 10.3389/fonc.2019.00318. eCollection 2019.

Organ preservation after a clinical complete response to radiochemotherapy is currently one of the most discussed topics in the management of rectal cancer. However, the patients' perspective has only been poorly studied so far. In this multicenter study, we...

Cite
Gani C, Gani N, Zschaeck S, et al. Organ Preservation in Rectal Cancer: The Patients' Perspective. Front Oncol. 2019;9:318doi: 10.3389/fonc.2019.00318.
Gani, C., Gani, N., Zschaeck, S., Eberle, F., Schaeffeler, N., Hehr, T., Berger, B., Fischer, S. G., Claßen, J., Zipfel, S., Rödel, C., Teufel, M., & Zips, D. (2019). Organ Preservation in Rectal Cancer: The Patients' Perspective. Frontiers in oncology, 9318. https://doi.org/10.3389/fonc.2019.00318
Gani, Cihan, et al. "Organ Preservation in Rectal Cancer: The Patients' Perspective." Frontiers in oncology vol. 9 (2019): 318. doi: https://doi.org/10.3389/fonc.2019.00318
Gani C, Gani N, Zschaeck S, Eberle F, Schaeffeler N, Hehr T, Berger B, Fischer SG, Claßen J, Zipfel S, Rödel C, Teufel M, Zips D. Organ Preservation in Rectal Cancer: The Patients' Perspective. Front Oncol. 2019 May 10;9:318. doi: 10.3389/fonc.2019.00318. eCollection 2019. PMID: 31134146; PMCID: PMC6524150.
Copy Download .nbib Format: NLM
Watchful Waiting after Radiochemotherapy in Rectal Cancer: When Is It Feasible?.

Visceral medicine

Gani C, Kirschniak A, Zips D.
PMID: 31192245
Visc Med. 2019 Apr;35(2):119-123. doi: 10.1159/000499167. Epub 2019 Mar 27.

A "watch and wait" strategy in rectal cancer is increasingly considered in patients who achieve an excellent response to radiotherapy. While a growing number of studies have shown the feasibility of this strategy in selected patients, the optimal therapeutic...

Cite
Gani C, Kirschniak A, Zips D. Watchful Waiting after Radiochemotherapy in Rectal Cancer: When Is It Feasible?. Visc Med. 2019;35(2):119-123doi: 10.1159/000499167.
Gani, C., Kirschniak, A., & Zips, D. (2019). Watchful Waiting after Radiochemotherapy in Rectal Cancer: When Is It Feasible?. Visceral medicine, 35(2), 119-123. https://doi.org/10.1159/000499167
Gani, Cihan, et al. "Watchful Waiting after Radiochemotherapy in Rectal Cancer: When Is It Feasible?." Visceral medicine vol. 35,2 (2019): 119-123. doi: https://doi.org/10.1159/000499167
Gani C, Kirschniak A, Zips D. Watchful Waiting after Radiochemotherapy in Rectal Cancer: When Is It Feasible?. Visc Med. 2019 Apr;35(2):119-123. doi: 10.1159/000499167. Epub 2019 Mar 27. PMID: 31192245; PMCID: PMC6514498.
Copy Download .nbib Format: NLM
A quantitative and qualitative RNA expression profiling assay for cell culture with single cell resolution.

Cytotechnology

Kraus P, Yerden R, Sipes D, Sur S, Lufkin T.
PMID: 28799096
Cytotechnology. 2018 Feb;70(1):185-192. doi: 10.1007/s10616-017-0132-1. Epub 2017 Aug 10.

Cells are often characterized by their gene expression profile. However, commonly used methods to detect mRNA require cell pooling and could therefore mask differences in gene expression within heterogeneous cell populations. q

Cite
Kraus P, Yerden R, Sipes D, et al. A quantitative and qualitative RNA expression profiling assay for cell culture with single cell resolution. Cytotechnology. 2017;70(1):185-192doi: 10.1007/s10616-017-0132-1.
Kraus, P., Yerden, R., Sipes, D., Sur, S., & Lufkin, T. (2018). A quantitative and qualitative RNA expression profiling assay for cell culture with single cell resolution. Cytotechnology, 70(1), 185-192. https://doi.org/10.1007/s10616-017-0132-1
Kraus, Petra, et al. "A quantitative and qualitative RNA expression profiling assay for cell culture with single cell resolution." Cytotechnology vol. 70,1 (2018): 185-192. doi: https://doi.org/10.1007/s10616-017-0132-1
Kraus P, Yerden R, Sipes D, Sur S, Lufkin T. A quantitative and qualitative RNA expression profiling assay for cell culture with single cell resolution. Cytotechnology. 2018 Feb;70(1):185-192. doi: 10.1007/s10616-017-0132-1. Epub 2017 Aug 10. PMID: 28799096; PMCID: PMC5809649.
Copy Download .nbib Format: NLM
Generation of deep ultraviolet sub-2-fs pulses.

Optics letters

Galli M, Wanie V, Lopes DP, Månsson EP, Trabattoni A, Colaizzi L, Saraswathula K, Cartella A, Frassetto F, Poletto L, Légaré F, Stagira S, Nisoli M, Martínez Vázquez R, Osellame R, Calegari F.
PMID: 30874637
Opt Lett. 2019 Mar 15;44(6):1308-1311. doi: 10.1364/OL.44.001308.

We demonstrate the generation of few-cycle deep ultraviolet pulses via frequency upconversion of 5-fs near-infrared pulses in argon using a laser-fabricated gas cell. The measured spectrum extends from 210 to 340 nm, corresponding to a transform-limited pulse duration of...

Cite
Galli M, Wanie V, Lopes DP, et al. Generation of deep ultraviolet sub-2-fs pulses. Opt Lett. 2019;44(6):1308-1311doi: 10.1364/OL.44.001308.
Galli, M., Wanie, V., Lopes, D. P., Månsson, E. P., Trabattoni, A., Colaizzi, L., Saraswathula, K., Cartella, A., Frassetto, F., Poletto, L., Légaré, F., Stagira, S., Nisoli, M., Martínez Vázquez, R., Osellame, R., & Calegari, F. (2019). Generation of deep ultraviolet sub-2-fs pulses. Optics letters, 44(6), 1308-1311. https://doi.org/10.1364/OL.44.001308
Galli, Mara, et al. "Generation of deep ultraviolet sub-2-fs pulses." Optics letters vol. 44,6 (2019): 1308-1311. doi: https://doi.org/10.1364/OL.44.001308
Galli M, Wanie V, Lopes DP, Månsson EP, Trabattoni A, Colaizzi L, Saraswathula K, Cartella A, Frassetto F, Poletto L, Légaré F, Stagira S, Nisoli M, Martínez Vázquez R, Osellame R, Calegari F. Generation of deep ultraviolet sub-2-fs pulses. Opt Lett. 2019 Mar 15;44(6):1308-1311. doi: 10.1364/OL.44.001308. PMID: 30874637.
Copy Download .nbib Format: NLM
Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy.

Clinical and translational radiation oncology

Bütof R, Gumina C, Valentini C, Sommerer A, Appold S, Zips D, Löck S, Baumann M, Troost EGC.
PMID: 29594227
Clin Transl Radiat Oncol. 2017 Nov 06;7:36-42. doi: 10.1016/j.ctro.2017.09.010. eCollection 2017 Dec.

OBJECTIVES: Concurrent radiochemotherapy (RCHT) is standard treatment in locally advanced small cell lung cancer (SCLC) patients. Due to conflicting results on elective nodal irradiation (ENI) or selective node irradiation (SNI) there is no clear evidence on optimal target volumes....

Cite
Bütof R, Gumina C, Valentini C, et al. Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy. Clin Transl Radiat Oncol. 2017;7:36-42doi: 10.1016/j.ctro.2017.09.010.
Bütof, R., Gumina, C., Valentini, C., Sommerer, A., Appold, S., Zips, D., Löck, S., Baumann, M., & Troost, E. G. C. (2017). Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy. Clinical and translational radiation oncology, 736-42. https://doi.org/10.1016/j.ctro.2017.09.010
Bütof, Rebecca, et al. "Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy." Clinical and translational radiation oncology vol. 7 (2017): 36-42. doi: https://doi.org/10.1016/j.ctro.2017.09.010
Bütof R, Gumina C, Valentini C, Sommerer A, Appold S, Zips D, Löck S, Baumann M, Troost EGC. Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy. Clin Transl Radiat Oncol. 2017 Nov 06;7:36-42. doi: 10.1016/j.ctro.2017.09.010. eCollection 2017 Dec. PMID: 29594227; PMCID: PMC5862679.
Copy Download .nbib Format: NLM
The patients view on genetics and functional imaging for precision medicine: a willingness-to-pay analysis.

Personalized medicine

Clasen K, Gani C, Schroeder C, Riess O, Zips D, Schöffski O, Clasen S.
PMID: 34984920
Per Med. 2022 Jan 05; doi: 10.2217/pme-2021-0067. Epub 2022 Jan 05.

No abstract available.

Cite
Clasen K, Gani C, Schroeder C, et al. The patients view on genetics and functional imaging for precision medicine: a willingness-to-pay analysis. Per Med. 2022;doi: 10.2217/pme-2021-0067.
Clasen, K., Gani, C., Schroeder, C., Riess, O., Zips, D., Schöffski, O., & Clasen, S. (2022). The patients view on genetics and functional imaging for precision medicine: a willingness-to-pay analysis. Personalized medicine, . https://doi.org/10.2217/pme-2021-0067
Clasen, Kerstin, et al. "The patients view on genetics and functional imaging for precision medicine: a willingness-to-pay analysis." Personalized medicine vol. (2022). doi: https://doi.org/10.2217/pme-2021-0067
Clasen K, Gani C, Schroeder C, Riess O, Zips D, Schöffski O, Clasen S. The patients view on genetics and functional imaging for precision medicine: a willingness-to-pay analysis. Per Med. 2022 Jan 05; doi: 10.2217/pme-2021-0067. Epub 2022 Jan 05. PMID: 34984920.
Copy Download .nbib Format: NLM
Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German Cancer Consortium - Radiation Oncology Group (DKTK-ROG).

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Martin D, Schreckenbach T, Ziegler P, Filmann N, Kalinauskaite G, Tinhofer I, Budach V, Gani C, Zips D, Schimek-Jasch T, Schäfer H, Grosu AL, Thomas E, Krause M, Dapper H, Combs S, Hoffmann C, Stuschke M, Walter F, Belka C, Kurth I, Hadiwikarta WW, Baumann M, Rödel C, Fokas E.
PMID: 34999135
Radiother Oncol. 2022 Jan 06; doi: 10.1016/j.radonc.2021.12.050. Epub 2022 Jan 06.

BACKGROUND AND PURPOSE: Prognosis after chemoradiotherapy (CRT) for anal squamous cell carcinoma (ASCC) shows marked differences among patients according to TNM subgroups, however individualized risk assessment tools to better stratify patients for treatment (de-) escalation or intensified follow-up are...

Cite
Martin D, Schreckenbach T, Ziegler P, et al. Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German Cancer Consortium - Radiation Oncology Group (DKTK-ROG). Radiother Oncol. 2022;doi: 10.1016/j.radonc.2021.12.050.
Martin, D., Schreckenbach, T., Ziegler, P., Filmann, N., Kalinauskaite, G., Tinhofer, I., Budach, V., Gani, C., Zips, D., Schimek-Jasch, T., Schäfer, H., Grosu, A. L., Thomas, E., Krause, M., Dapper, H., Combs, S., Hoffmann, C., Stuschke, M., Walter, F., Belka, C., Kurth, I., Hadiwikarta, W. W., Baumann, M., Rödel, C., & Fokas, E. (2022). Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German Cancer Consortium - Radiation Oncology Group (DKTK-ROG). Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, . https://doi.org/10.1016/j.radonc.2021.12.050
Martin, D, et al. "Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German Cancer Consortium - Radiation Oncology Group (DKTK-ROG)." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. (2022). doi: https://doi.org/10.1016/j.radonc.2021.12.050
Martin D, Schreckenbach T, Ziegler P, Filmann N, Kalinauskaite G, Tinhofer I, Budach V, Gani C, Zips D, Schimek-Jasch T, Schäfer H, Grosu AL, Thomas E, Krause M, Dapper H, Combs S, Hoffmann C, Stuschke M, Walter F, Belka C, Kurth I, Hadiwikarta WW, Baumann M, Rödel C, Fokas E. Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German Cancer Consortium - Radiation Oncology Group (DKTK-ROG). Radiother Oncol. 2022 Jan 06; doi: 10.1016/j.radonc.2021.12.050. Epub 2022 Jan 06. PMID: 34999135.
Copy Download .nbib Format: NLM
Hypofractionated preoperative radiotherapy for high risk soft tissue sarcomas in a geriatric patient population.

Radiology and oncology

Potkrajcic V, Traub F, Hermes B, Scharpf M, Kolbenschlag J, Zips D, Paulsen F, Eckert F.
PMID: 34821137
Radiol Oncol. 2021 Nov 19;55(4):459-466. doi: 10.2478/raon-2021-0038.

BACKGROUND: Standard therapy for localised, resectable high risk soft tissue sarcomas consists of wide excision and radiotherapy over several weeks. This treatment schedule is hardly feasible in geriatric and frail patients. In order not to withhold radiotherapy from these...

Cite
Potkrajcic V, Traub F, Hermes B, et al. Hypofractionated preoperative radiotherapy for high risk soft tissue sarcomas in a geriatric patient population. Radiol Oncol. 2021;55(4):459-466doi: 10.2478/raon-2021-0038.
Potkrajcic, V., Traub, F., Hermes, B., Scharpf, M., Kolbenschlag, J., Zips, D., Paulsen, F., & Eckert, F. (2021). Hypofractionated preoperative radiotherapy for high risk soft tissue sarcomas in a geriatric patient population. Radiology and oncology, 55(4), 459-466. https://doi.org/10.2478/raon-2021-0038
Potkrajcic, Vlatko, et al. "Hypofractionated preoperative radiotherapy for high risk soft tissue sarcomas in a geriatric patient population." Radiology and oncology vol. 55,4 (2021): 459-466. doi: https://doi.org/10.2478/raon-2021-0038
Potkrajcic V, Traub F, Hermes B, Scharpf M, Kolbenschlag J, Zips D, Paulsen F, Eckert F. Hypofractionated preoperative radiotherapy for high risk soft tissue sarcomas in a geriatric patient population. Radiol Oncol. 2021 Nov 19;55(4):459-466. doi: 10.2478/raon-2021-0038. PMID: 34821137; PMCID: PMC8647799.
Copy Download .nbib Format: NLM
Showing 85 to 96 of 98 entries